These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9153542)

  • 1. Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction.
    Horwitz DA; Tang FL; Stimmler MM; Oki A; Gray JD
    Arthritis Rheum; 1997 May; 40(5):822-33. PubMed ID: 9153542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD2-mediated T-lymphocyte proliferation in patients with systemic lupus erythematosus].
    Tang FL
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):661-3, 701. PubMed ID: 7907269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
    Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
    Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
    Carabasi MH; DiSanto JP; Yang SY; Dupont B
    Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
    Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
    Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The classical and alternative pathways of T-lymphocyte activation in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 1999; 71(5):30-4. PubMed ID: 10399227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced proliferation in T lymphocytes in aged humans is predominantly in the CD8+ subset, and is unrelated to defects in transmembrane signaling which are predominantly in the CD4+ subset.
    Grossmann A; Ledbetter JA; Rabinovitch PS
    Exp Cell Res; 1989 Feb; 180(2):367-82. PubMed ID: 2521605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis.
    Kaneko H; Saito K; Hashimoto H; Yagita H; Okumura K; Azuma M
    Clin Exp Immunol; 1996 Nov; 106(2):218-29. PubMed ID: 8918566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
    Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
    J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
    Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic activity of anti-CD28 MoAb CLB-CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti-T cells MoAb in the activation of purified T lymphocytes.
    De Felice M; Giarrusso PC; Lamberti A; Turco MC; Valerio G; van Lier RA; Yang SY; Ferrone S; Venuta S
    Tissue Antigens; 1990 Jul; 36(1):12-8. PubMed ID: 1701062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation of CD3/TcR complex with either integrin or nonintegrin ligands protects CD4+ allergen-specific T-cell clones from programmed cell death.
    Agea E; Bistoni O; Bini P; Migliorati G; Nicoletti I; Bassotti G; Riccardi C; Bertotto A; Spinozzi F
    Allergy; 1995 Aug; 50(8):677-82. PubMed ID: 7503404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection.
    Wu CS; Chyuan IT; Chiu YL; Chen WL; Shen CY; Hsu PN
    Rheumatology (Oxford); 2020 Nov; 59(11):3340-3349. PubMed ID: 32306043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells.
    Stohl W; Hamilton AS; Deapen DM; Mack TM; Horwitz DA
    Lupus; 1999; 8(4):293-9. PubMed ID: 10413208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.
    Honda M; Mengesha E; Albano S; Nichols WS; Wallace DJ; Metzger A; Klinenberg JR; Linker-Israeli M
    Clin Immunol; 2001 May; 99(2):211-221. PubMed ID: 11318593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
    Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.